泌尿生殖道支原体培养及药敏结果分析

Analysis of Uregenital Tract Mycoplasma Culture and Their Susceptibility to Antibiotics

目的 探讨解脲支原体(UU)和人型支原体(MH)在非淋菌性尿道炎(NGU)中的感染及药敏情况。方法 应用法国生物——梅里埃公司生产的MYCOPLASMA IST试剂盒进行培养及药敏试验。结果 780例检测标本中,267例支原体培养阳性,检出率34.2％。其中UU阳性209例(26.8％),MH阳性23例(2.9％),UU+MH混合阳性35例(4.5％)对原始霉素,交沙霉素,强力霉素和氧氟沙星敏感率分别为100％,94.7％,83.1％和76.0％。对红霉素和四环素敏感率分别为49.8％和48.7％、结论UU及MH感染是NGU感染的重要病原体。对STD患者应尽可能作UU和MU捡测。临床治疗应首选交沙霉素和强力霉素,不宜选用红霉素和四环素治疗。

Objective To explore the infection of Uroplasma Urealytica(UU)and Mycoplasma Hominis(MH)in Non Gonococeal Uretitis(NGU)and the susceptibility to antibiotics. Methods Mycoplasma IST kits made in France were used. Results 267 of 780 cases were infected with mycoplasma. The total positive rate was 34. 2 % . Among them, the positve rates of UU, MH and mixed together infection were 26.8% ( 209cases), 2. 9% (23cases)and 4. 5% (35cases) respectively. Their susceptibility rates to Pristinamyccine, Josamycine( Jos), Doxycycline( Dox) and Ofloxacine were 100 % , 94. 7 % , 83. 1 % and 76. 0 % respectively. The susceptibility rates to Erythromycine(Ery)and Tetracycline(Tet)were 49.8and 48.7% Conclusion UU and MH infection were the important pathogens in NGU. It is necessary to detect UU and MH for STD patients. Jos and Dox arc the first choices to treat NGU,and it is unsuitable to treat NGU by Ery and Tet.